International Journal of Pharmaceutics: X最新文献

筛选
英文 中文
Investigating the effect of whey and casein proteins on drug solubility from a paediatric drug absorption perspective 从儿科药物吸收角度研究乳清蛋白和酪蛋白对药物溶解度的影响
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-10-09 DOI: 10.1016/j.ijpx.2024.100290
Matthias Van der Veken , Joachim Brouwers , Neil Parrott , Patrick Augustijns , Cordula Stillhart
{"title":"Investigating the effect of whey and casein proteins on drug solubility from a paediatric drug absorption perspective","authors":"Matthias Van der Veken ,&nbsp;Joachim Brouwers ,&nbsp;Neil Parrott ,&nbsp;Patrick Augustijns ,&nbsp;Cordula Stillhart","doi":"10.1016/j.ijpx.2024.100290","DOIUrl":"10.1016/j.ijpx.2024.100290","url":null,"abstract":"<div><div>Considering the predominantly milk-based diet of neonates and infants and their immature gastrointestinal digestion, milk proteins may affect drug behaviour and absorption in this population. Using in vitro models, this study investigated the impact of the representative milk proteins, whey and casein, on the solubility and permeation of the lipophilic model drugs spironolactone, clopidogrel and ritonavir. Drug solubility experiments revealed that the presence of milk proteins increased drug solubility. Next, permeation studies demonstrated that the same milk proteins reduced drug permeation across an artificial membrane. These results highlight the importance of the solubility-permeability interplay and indicate the effect of these proteins may be considered during (paediatric) drug development. Lastly, the findings underscore the importance of considering milk protein-drug interactions to optimize drug delivery strategies during (paediatric) drug development and especially for the youngest and most vulnerable part of this population.</div></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100290"},"PeriodicalIF":5.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiaging synergistic effect in noninvasive transdermal delivery of peptide loaded liposomes by low energy/frequency radiofrequency 低能量/高频射频非侵入性透皮给药多肽脂质体的抗衰老协同效应
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-10-05 DOI: 10.1016/j.ijpx.2024.100289
Nanxi Xiang , Zeting Huang , Chunqiao Zhang , Jiahong Huang , Zhenyuan Wang , Jichuan Zhang , Chengyu Wu , Weihua Peng , Jiaheng Zhang
{"title":"Antiaging synergistic effect in noninvasive transdermal delivery of peptide loaded liposomes by low energy/frequency radiofrequency","authors":"Nanxi Xiang ,&nbsp;Zeting Huang ,&nbsp;Chunqiao Zhang ,&nbsp;Jiahong Huang ,&nbsp;Zhenyuan Wang ,&nbsp;Jichuan Zhang ,&nbsp;Chengyu Wu ,&nbsp;Weihua Peng ,&nbsp;Jiaheng Zhang","doi":"10.1016/j.ijpx.2024.100289","DOIUrl":"10.1016/j.ijpx.2024.100289","url":null,"abstract":"<div><div>Low energy/frequency radiofrequency (LRF) combined with the transdermal delivery of liposome (L) encapsulated antiaging peptides technology is a remarkable, newly developed physical noninvasive transdermal penetration technique; it is considered a highly efficient, comprehensive and safe technology. In this study, our objective was to evaluate the physical and chemical mechanisms underlying the efficacy of this innovative technique involving a combination of LRF and L, termed LLRF, that exerts a synergistic anti-aging effect on human skin, via an animal experiment. Physical and chemical analyses indicated that a relatively stable liposome with a uniform nano-size, which was formed, possessed good transdermal permeability that was 2.74 folds higher than that of the free peptide (F). LLRF exhibited a higher transdermal permeation performance that was of 3.65 folds higher than that of the free one, which was substantiated via confocal laser scanning fluorescence microscopy. The mouse UVB photoaging model trial confirmed that the LLRF technology exerted a significant synergistic effect compared to liposome technology, or free peptide, by downregulating inflammatory factors (IL-6, TNF-α), inhibiting the mRNA and protein expression of matrix metalloproteinases (MMP1, MMP3), promoting the mRNA and protein expression of related collagens (Procollagen, Col1α1 and Col3α1), and repairing the stratum corneum barrier function, as evidenced by trans-epidermal water loss (TEWL), skin cuticle hydration (SCH), and decreased expression of β-gal, an aging marker. These findings indicated that photoaging skin can be effectively and comprehensively rejuvenated, and that even photodamage can be reversed, thereby restoring the original physiological characteristics of healthy skin. Clinical tests have confirmed that although liposome technology is an effective antiaging method which helps exert tightening and anti-wrinkle effects on human skin, LLRF is an even more effective anti-aging technique. This study reveals a highly effective technique involving a combination physical and chemical therapy that may be utilized for antiaging purposes as well as repairing lightly damaged skin, and can be made readily available in the future.</div></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100289"},"PeriodicalIF":5.2,"publicationDate":"2024-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoencoder-based inverse design and surrogate-based optimization of an integrated wet granulation manufacturing process 基于自动编码器的湿法造粒集成制造工艺的逆向设计和代用优化
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-09-26 DOI: 10.1016/j.ijpx.2024.100287
Ashley Dan, Rohit Ramachandran
{"title":"Autoencoder-based inverse design and surrogate-based optimization of an integrated wet granulation manufacturing process","authors":"Ashley Dan,&nbsp;Rohit Ramachandran","doi":"10.1016/j.ijpx.2024.100287","DOIUrl":"10.1016/j.ijpx.2024.100287","url":null,"abstract":"<div><div>In pharmaceutical manufacturing, integrating model-based design and optimization can be beneficial for accelerating process development. This study explores the utilization of Machine Learning (ML) techniques as a surrogate model for the optimization of a three-unit wet-granulation based flowsheet model for solid dosage form manufacturing. First, a reduced representation of a wet granulation flowsheet model is developed, incorporating a granulation and milling process, along with a novel dissolution model that accounts for the effect of particle size, porosity, and microstructure on dissolution rate. Two optimization approaches are compared, including an autoencoder-based inverse design and a surrogate-based forward optimization. Both methods address the bi-objective problem of maximizing dissolution time and product yield by identifying the optimal granulation and mill process parameters. For this case study, both approaches were effective and incurred a similar computational cost, averaging under 4 s. However, the autoencoder approach offers an advantage through dimensionality reduction, a feature not available in surrogate-based optimization. Dimensional reduction is particularly beneficial for complex process designs with numerous inputs and outputs. The lower dimensional representation helps improve process understanding through enhanced visualization of the process design space and facilitates feasibility studies involving multiple constraints. The autoencoder-based inverse design introduced in this work showcases an implementation of AI and ML in pharmaceutical process development, demonstrating the potential to enhance process efficiency and product quality in complex manufacturing scenarios.</div></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100287"},"PeriodicalIF":5.2,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142420610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifunctional Bi2S3-Au nanoclusters for fluorescence/infrared thermal imaging guided photothermal therapy 用于荧光/红外热成像引导光热疗法的多功能 Bi2S3-Au 纳米团簇
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-09-17 DOI: 10.1016/j.ijpx.2024.100286
Hongmei Sun , Yuyu Cao , Beibei Zhai , Xiaoshuang Zhao , Xuejun Zhang , Jiangtao Su
{"title":"Multifunctional Bi2S3-Au nanoclusters for fluorescence/infrared thermal imaging guided photothermal therapy","authors":"Hongmei Sun ,&nbsp;Yuyu Cao ,&nbsp;Beibei Zhai ,&nbsp;Xiaoshuang Zhao ,&nbsp;Xuejun Zhang ,&nbsp;Jiangtao Su","doi":"10.1016/j.ijpx.2024.100286","DOIUrl":"10.1016/j.ijpx.2024.100286","url":null,"abstract":"<div><div>Nanotechnology has attracted extensive attention in the diagnosis and treatment of cancer. Therefore, the research aimed at developing new nanomaterials and exploring their applications in biomedicine has attracted more attention. In this study, Bi<sub>2</sub>S<sub>3</sub>-Au nanoclusters (Bi<sub>2</sub>S<sub>3</sub>-AuNCs) as fluorescence/infrared thermal imaging-guided photothermal therapy (PTT) was prepared for the first time. It was achieved in a facile and mild way by optimizing the amount of Bi<sup>3+</sup> and Au<sup>3+</sup> using bovine serum albumin (BSA) as reducer and stabilizer. The as-prepared Bi<sub>2</sub>S<sub>3</sub>-AuNCs with special morphology showed high stability, excellent biocompatibility and good photostability. Apart from these, it also can accumulate at tumor sites and exhibit considerable fluorescence/infrared thermal imaging-guided PTT. Bi<sub>2</sub>S<sub>3</sub>-AuNCs nanoparticles integrate imaging and therapeutic functions into an advanced application platform, which provides the possibility to build a novel nano-cancer diagnosis and treatment platform.</div></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100286"},"PeriodicalIF":5.2,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000586/pdfft?md5=70c1d210ccb12e79699cce62e385f85d&pid=1-s2.0-S2590156724000586-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations 他克莫司理化稳定性挑战、分析方法和新制剂
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-09-15 DOI: 10.1016/j.ijpx.2024.100285
Sara Sajjadi , Ali Shayanfar , Farhad Kiafar , Mohammadreza Siahi-Shadbad
{"title":"Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations","authors":"Sara Sajjadi ,&nbsp;Ali Shayanfar ,&nbsp;Farhad Kiafar ,&nbsp;Mohammadreza Siahi-Shadbad","doi":"10.1016/j.ijpx.2024.100285","DOIUrl":"10.1016/j.ijpx.2024.100285","url":null,"abstract":"<div><p>Tacrolimus, a potent immunosuppressant, is widely used in several formulations to treat organ rejection in transplant patients. However, its physicochemical stability poses significant challenges, including thermal instability, photostability issues, low solubility, and drug-excipient incompatibility. This review article focuses on the details of these challenges and discusses the analytical methods employed to study tacrolimus stability, such as thermal, spectroscopic, and chromatographic methods in different formulations. New formulations to enhance tacrolimus stability are explored, including lipid-based nanocarriers, polymers, and thin film freezing. Researchers and formulators can optimize tacrolimus formulations to improve efficacy and patient outcomes by understanding and addressing these stability challenges.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100285"},"PeriodicalIF":5.2,"publicationDate":"2024-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000574/pdfft?md5=8e4f3b8fafab43bb3c880135d2d3f038&pid=1-s2.0-S2590156724000574-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142241911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a novel intramuscular liposomal injection for advanced meloxicam delivery: Preparation, characterization, in vivo pharmacokinetics, pharmacodynamics, and pain assessment in an orthopedic pain model 开发新型肌肉注射脂质体,用于美洛昔康的高级给药:骨科疼痛模型的制备、表征、体内药代动力学、药效学和疼痛评估
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-09-14 DOI: 10.1016/j.ijpx.2024.100284
Pierre A. Hanna , Hatim A. Al-Abbadi , Mohamed A. Hashem , Aziza E. Mostafa , Yasmina K. Mahmoud , Eman A. Ahmed , Ibrahim M. Hegab , Ibrahim E. Helal , Mahmoud F. Ahmed
{"title":"Development of a novel intramuscular liposomal injection for advanced meloxicam delivery: Preparation, characterization, in vivo pharmacokinetics, pharmacodynamics, and pain assessment in an orthopedic pain model","authors":"Pierre A. Hanna ,&nbsp;Hatim A. Al-Abbadi ,&nbsp;Mohamed A. Hashem ,&nbsp;Aziza E. Mostafa ,&nbsp;Yasmina K. Mahmoud ,&nbsp;Eman A. Ahmed ,&nbsp;Ibrahim M. Hegab ,&nbsp;Ibrahim E. Helal ,&nbsp;Mahmoud F. Ahmed","doi":"10.1016/j.ijpx.2024.100284","DOIUrl":"10.1016/j.ijpx.2024.100284","url":null,"abstract":"<div><p>Pain produces several physiological, and degenerative complications. This study aimed to formulate meloxicam (MLX) in liposomes to increase solubility and deliver MLX in a controlled manner to overcome its poor aqueous solubility and relatively short t<sub>1/2</sub> problems. Liposomes were prepared by thin film hydration followed by ultrasonication. Tests for characterizing formulations included particle size, span, entrapment efficiency, drug loading, stability, differential scanning calorimetry (DSC), Fourier transformation infrared (FT-IR) spectroscopy, morphology, <em>in vitro</em> release, release kinetics mathematical modeling, and an <em>in vivo</em> pain model in dogs undergoing orthopedic surgeries, followed by <em>in vivo</em> pharmacokinetics, pharmacodynamics, and pain assessment studies in comparison to the reference standard, Mobitil®. Liposomal MLX had a particle size of around 100 nm, 82 % entrapment efficiency, and 4.62 % drug loading. Stability studies, DSC, and FT-IR spectroscopy indicated that liposomes were highly stable. The formulation showed an improved <em>in vitro</em> controlled release pattern and an enhanced <em>in vivo</em> pharmacokinetic behavior as manifested by higher t<sub>1/2</sub> and AUC<sub>0</sub><sub>–</sub><sub>24</sub> and lower Cl/F in comparison to Mobitil®. The pharmacodynamics study and pain scales demonstrated liposomal MLX managed postoperative pain better than Mobitil®. In conclusion, the incorporation of MLX in liposomes increased its solubility and stability, as well as its pain management properties.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100284"},"PeriodicalIF":5.2,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000562/pdfft?md5=eceec16a3d26a2520d27669657dd08b7&pid=1-s2.0-S2590156724000562-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142242673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery 用于递送 RNA 的脂质纳米粒子配方和制备的综合分析
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-09-10 DOI: 10.1016/j.ijpx.2024.100283
Md. Anamul Haque , Archana Shrestha , Constantinos M. Mikelis , George Mattheolabakis
{"title":"Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery","authors":"Md. Anamul Haque ,&nbsp;Archana Shrestha ,&nbsp;Constantinos M. Mikelis ,&nbsp;George Mattheolabakis","doi":"10.1016/j.ijpx.2024.100283","DOIUrl":"10.1016/j.ijpx.2024.100283","url":null,"abstract":"<div><p>Nucleic acid-based therapeutics are a common approach that is increasingly popular for a wide spectrum of diseases. Lipid nanoparticles (LNPs) are promising delivery carriers that provide RNA stability, with strong transfection efficiency, favorable and tailorable pharmacokinetics, limited toxicity, and established translatability. In this review article, we describe the lipid-based delivery systems, focusing on lipid nanoparticles, the need of their use, provide a comprehensive analysis of each component, and highlight the advantages and disadvantages of the existing manufacturing processes. We further summarize the ongoing and completed clinical trials utilizing LNPs, indicating important aspects/questions worth of investigation, and analyze the future perspectives of this significant and promising therapeutic approach.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100283"},"PeriodicalIF":5.2,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000550/pdfft?md5=e551d8567346b9e628303c13978d4db3&pid=1-s2.0-S2590156724000550-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142173119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A simple nanoplatform of thermo-sensitive liposomes and gold nanorods to treat bone metastasis through improved chemotherapy combined with photothermal therapy 一种简单的热敏脂质体和金纳米棒纳米平台,通过改进化疗结合光热疗法治疗骨转移瘤
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-08-30 DOI: 10.1016/j.ijpx.2024.100282
Jia Gu , Lifan Jiang , Zhongping Chen , Jun Qi
{"title":"A simple nanoplatform of thermo-sensitive liposomes and gold nanorods to treat bone metastasis through improved chemotherapy combined with photothermal therapy","authors":"Jia Gu ,&nbsp;Lifan Jiang ,&nbsp;Zhongping Chen ,&nbsp;Jun Qi","doi":"10.1016/j.ijpx.2024.100282","DOIUrl":"10.1016/j.ijpx.2024.100282","url":null,"abstract":"<div><p>Bone metastasis remains a clinical challenge and is still considered incurable. While nanoparticles-based drug delivery and photothermal therapy (PTT) show promise in treating subcutaneous solid tumor, their therapeutic outcome in treating bone metastasis is limited, due to the inaccessibility of bone metastatic site and the complexity of bone metastasis. Herein, we reported a simple nanoplatform composed of thermo-sensitive liposomes (TSL) and gold nanorods (GNR) to treat bone metastasis through improved chemotherapy combined with GNR-assisted PTT. Lipid combination of TSL was firstly tailored to regulate its stability under physiological condition as well as its sensitivity in responding to PTT-caused mild hyperthermia. The obtained TSL with loaded drug was then combined with GNR to form the nanoplatform through unsophisticated incubation. Cell experiments revealed that upon near-infrared (NIR) irradiation, the nanoplatform effectively inhibited the viability and migration ability of tumor cells through PTT, PTT-triggered thermo-sensitive drug release, and PTT-augmented sensitivity of tumor cells to drug. In a murine model of bone metastasis, the nanoplatform enabled effective delivery of loaded drug and GNR to bone metastatic site for rapid drug release upon local NIR irradiation. Through killing tumor cells and rebalancing the turnover of osteoclasts and osteoblasts, the nanoplatform largely preserved bone structure for pain relief and survival extension. Inspired by the simplicity of nanoplatform acquirement and treatment operation, the strategy of liposomes-based thermo-sensitive drug delivery in combination with GNR-assisted PTT is considered greatly promising in treating bone metastasis.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100282"},"PeriodicalIF":5.2,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000549/pdfft?md5=331f32a9e21d2b357a1480cfb17abc30&pid=1-s2.0-S2590156724000549-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles 利用纳米颗粒和壳聚糖基纳米颗粒递送抗癌药物的研究进展
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-08-28 DOI: 10.1016/j.ijpx.2024.100281
Jarmila Prieložná , Veronika Mikušová , Peter Mikuš
{"title":"Advances in the delivery of anticancer drugs by nanoparticles and chitosan-based nanoparticles","authors":"Jarmila Prieložná ,&nbsp;Veronika Mikušová ,&nbsp;Peter Mikuš","doi":"10.1016/j.ijpx.2024.100281","DOIUrl":"10.1016/j.ijpx.2024.100281","url":null,"abstract":"<div><p>Cancer is the leading cause of death globally, and conventional treatments have limited efficacy with severe side effects. The use of nanotechnology has the potential to reduce the side effects of drugs by creating efficient and controlled anticancer drug delivery systems. Nanoparticles (NPs) used as drug carriers offer several advantages, including enhanced drug protection, biodistribution, selectivity and, pharmacokinetics. Therefore, this review is devoted to various organic (lipid, polymeric) as well as inorganic nanoparticles based on different building units and providing a wide range of potent anticancer drug delivery systems. Within these nanoparticulate systems, chitosan (CS)-based NPs are discussed with particular emphasis due to the unique properties of CS and its derivatives including non-toxicity, biodegradability, mucoadhesivity, and tunable physico-chemical as well as biological properties allowing their alteration to specifically target cancer cells. In the context of streamlining the nanoparticulate drug delivery systems (DDS), innovative nanoplatform-based cancer therapy pathways involving passive and active targeting as well as stimuli-responsive DDS enhancing overall orthogonality of developed NP-DDS towards the target are included. The most up-to-date information on delivering anti-cancer drugs using modern dosage forms based on various nanoparticulate systems and, specifically, CSNPs, are summarised and evaluated concerning their benefits, limitations, and advanced applications.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100281"},"PeriodicalIF":5.2,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000537/pdfft?md5=4dbe4aebcc1bb1aced4fd832c6a945fc&pid=1-s2.0-S2590156724000537-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142150047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways 白藜芦醇脂质体通过调节 PI3K-AKT-mTOR 和 VHL-HIF 信号通路逆转肾细胞癌模型的索拉非尼耐药性
IF 5.2 2区 医学
International Journal of Pharmaceutics: X Pub Date : 2024-08-26 DOI: 10.1016/j.ijpx.2024.100280
Ligang Wang , Ying Wang , Qiqi Xie , Songcheng Xu , Chen Yang , Fei Liu , Yang Liu , Fuwei Wang , Weinan Chen , Jianchun Li , Litao Sun
{"title":"Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways","authors":"Ligang Wang ,&nbsp;Ying Wang ,&nbsp;Qiqi Xie ,&nbsp;Songcheng Xu ,&nbsp;Chen Yang ,&nbsp;Fei Liu ,&nbsp;Yang Liu ,&nbsp;Fuwei Wang ,&nbsp;Weinan Chen ,&nbsp;Jianchun Li ,&nbsp;Litao Sun","doi":"10.1016/j.ijpx.2024.100280","DOIUrl":"10.1016/j.ijpx.2024.100280","url":null,"abstract":"<div><p>RCC is a malignant tumor arising from the urothelium of renal parenchyma that remains challenging to be treated. In this study, we assessed the anti-tumor effects of Resveratrol liposomes (RES-lips) combined with sorafenib on renal cell carcinoma (RCC) and explored the potential mechanisms underlying the improvement of sorafenib resistance models. Tumor growth and survival following treatment with sorafenib alone or in combination with RES-lips was evaluated in a RCC xenograft mouse model. Flow cytometry results demonstrated that the combination of RES-lips and sorafenib significantly enhanced the G1/S phase arrest of sorafenib-resistant cells. When compared with the PBS or monotherapy groups, treatment with RES-lips combined with sorafenib exhibited significant inhibition of tumor growth in the RCC xenograft mouse model with tumor growth inhibition (TGI) rates and complete remission (CR) rates of 90.1 % and 50 %, respectively. Concersely, the maximum TGI rate was 53.6 % in the RES-lips monoherapy group and 29.2 % and in the sorafenib monotherapy group, and no animals achieved CR. Additionally, the current combination therapy promoted the proliferation of unactivated splenic lymphocytes and the proliferation of soybean protein A- and lipopolysaccharide-stimulated lymphocytes compared with PBS or monotherapy treatments. Further western blotting analysis suggested that RES-lips may enhance the resistance of RCC to sorafenib by inhibiting PI3K-AKT-mTOR and VHL-HIF signaling pathways, ultimately augmenting the tumor growth inhibition effect of the combination therapy. RES-lips may improve the sorafenib resistance in RCC, and the underlying mechanism may be related to the regulation of PI3K-AKT-mTOR and VHL-HIF signaling pathways.</p></div>","PeriodicalId":14280,"journal":{"name":"International Journal of Pharmaceutics: X","volume":"8 ","pages":"Article 100280"},"PeriodicalIF":5.2,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590156724000525/pdfft?md5=344e55a6ece6c5530dbab79dc8f40ae8&pid=1-s2.0-S2590156724000525-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142098371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信